Email Newsletters

Life Sciences

SCIEX launches new software and protein analysis system

Framingham biotech company SCIEX on Wednesday announced the launch of two new initiatives, a software and a capillary electrophoresis system.

Pillar Biosciences announces new CEO

Pillar Biosciences in Natick announced on Wednesday the appointment of Randy Pritchard as CEO, as the company’s founder and previous CEO Dr. Gang Song will transition to the role of chairman of the board, according to a press release.

Natick biotech co. closes $53M in financing for stem cell product

HebeCell Corp., a Natick research company focused on therapies for cancer and autoimmune disease, announced on Tuesday it has closed a $53-million Series A financing for an off-the-shelf stem cell product.

MassBio hires senator as new CEO

MassBio, a not-for-profit organization in Cambridge focusing on the life sciences industry in Massachusetts, appointed State Sen. Joseph Boncore, a Democrat from the First Suffolk and Middlesex District, as CEO in an announcement on Wednesday.
ADVERTISEMENT

Boston Scientific closes $1.1B Israeli acquisition

Marlborough medical device manufacturer Boston Scientific Corp. acquired Lumenis, an Israel-based surgical company specializing in urological lasers, in a $1.1-billion deal announced on Wednesday.

Mass. biopharma industry swells with Worcester topping charts, says report

A burst in the Mass. biopharmaceutical industry over the last year has dilated the sector’s employment and real estate demand, according to a Wednesday report from MassBio.

Mustang Bio reports $14.4M loss

Mustang Bio, Inc., a clinical-stage biopharmaceutical company in Worcester, reported a net loss of $14.4 million for the company’s second quarter in an earnings report released last Monday.

ReWalk hires biotech executive to lead strategy

ReWalk Robotics Ltd., an Israeli manufacturer of robotic medical devices for individuals with lower limb disabilities, which has its U.S. headquarters in Marlborough, announced Jeannine Lynch’s appointment as the new vice president of strategy and market access.
ADVERTISEMENT

WuXi Biologics approved for expansion of $60M Worcester facility

The Chinese manufacturer WuXi Biologics, which is building a facility at The Reactory biomanufacturing campus on Belmont Street, was approved for a 5,000-square-foot expansion by the Worcester Planning Board on Wednesday night.

Hopkinton biotech partners with San Francisco tech firm

Lykan Bioscience, a Hopkinton manufacturer specializing in cell-based therapies, announced Thursday a partnership with San Francisco software company Vineti.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA